What does LERTE mean in MEDICAL
LERTE, an acronym for Laparoscopic Extraperitoneal Renal Tumor Enucleation, is a minimally invasive surgical technique used to remove tumors from the outer layer of the kidney, known as the renal capsule. This procedure offers significant advantages over traditional open surgery, such as reduced scarring, faster recovery time, and less pain.
LERTE meaning in Medical in Medical
LERTE mostly used in an acronym Medical in Category Medical that means Laparoscopic Extraperitoneal Renal Tumor Enucleation
Shorthand: LERTE,
Full Form: Laparoscopic Extraperitoneal Renal Tumor Enucleation
For more information of "Laparoscopic Extraperitoneal Renal Tumor Enucleation", see the section below.
LERTE Procedure
LERTE is performed through several small incisions in the abdomen. A laparoscope, a thin tube with a camera attached, is inserted through one of the incisions, allowing the surgeon to visualize the kidney. Specialized instruments are then used to create a space between the tumor and the renal capsule. The tumor is then carefully enucleated, or lifted out, without damaging the surrounding healthy kidney tissue.
Advantages of LERTE
- Minimally invasive: LERTE is performed laparoscopically, which minimizes scarring and reduces pain compared to traditional open surgery.
- Faster recovery: Patients typically recover from LERTE within a few days, compared to several weeks for open surgery.
- Reduced risk of complications: LERTE involves less manipulation of the kidney and surrounding structures, reducing the risk of bleeding, infection, and other complications.
- Preservation of kidney function: By selectively removing only the tumor, LERTE helps preserve as much of the healthy kidney tissue as possible, maintaining overall kidney function.
Indications for LERTE
LERTE is commonly used to treat small, localized tumors on the outer surface of the kidney, such as:
- Benign tumors (e.g., angiomyolipomas, oncocytomas)
- Small (<4 cm) renal cell carcinomas
- Metastatic tumors to the kidney
Contraindications for LERTE
LERTE may not be suitable for patients with:
- Tumors that are too large or complex
- Tumors that have invaded the renal sinus or surrounding structures
- Advanced kidney disease or poor overall health
Essential Questions and Answers on Laparoscopic Extraperitoneal Renal Tumor Enucleation in "MEDICAL»MEDICAL"
What is LERTE?
Laparoscopic Extraperitoneal Renal Tumor Enucleation (LERTE) is a minimally invasive surgical procedure used to remove small renal tumors while preserving the surrounding healthy kidney tissue.
How is LERTE performed?
LERTE involves creating a small incision in the abdomen and inserting a laparoscope, a narrow tube with a camera attached, to visualize the kidney and tumor. The surgeon then makes an incision in the kidney capsule, the outer layer of the kidney, and carefully separates the tumor from the surrounding tissue using specialized instruments.
Who is a candidate for LERTE?
LERTE is generally suitable for patients with small renal tumors (typically less than 4 centimeters in diameter) that are located on the outer surface of the kidney. Other factors such as the patient's overall health and the location of the tumor may also influence suitability.
What are the benefits of LERTE?
Compared to traditional open surgery, LERTE offers several advantages, including:
- Minimal scarring
- Reduced pain
- Shorter recovery time
- Preservation of healthy kidney tissue
What are the risks of LERTE?
As with any surgical procedure, LERTE carries potential risks, such as:
- Bleeding
- Infection
- Damage to the kidney or surrounding organs
- Recurrence of the tumor
How long does it take to recover from LERTE?
The recovery time after LERTE varies depending on the individual patient. Typically, patients can expect to stay in the hospital for a few days and may experience some discomfort or pain for several weeks. Most patients are able to return to normal activities within 4-6 weeks.
What is the success rate of LERTE?
The success rate of LERTE is generally high, with most studies reporting a low rate of tumor recurrence. The long-term outcomes and overall survival rates are comparable to traditional open surgery.
Is LERTE covered by insurance?
Coverage for LERTE varies depending on the insurance plan and specific circumstances. It is recommended to contact your insurance provider to determine if the procedure is covered.
Final Words: LERTE is a safe and effective minimally invasive surgical technique for removing tumors from the outer layer of the kidney. It offers numerous advantages over traditional open surgery, including reduced scarring, faster recovery, and preservation of kidney function. LERTE is a valuable treatment option for patients with small, localized renal tumors.